Insider trades
Kumar Rakhi, Director of NeuroPace NPCE, has filed 0 purchases and 14 sales on the open market. The latest trade was on 06/19.
Kumar Rakhi
Director
- Company
- NeuroPace NPCE
- First filing
- 23/01/26
- Trades
- 100 trades
- Buys / sales
- 0 / 14
- 12-month net buying
- No record
- Last trade
- 06/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Roivant SciencesROIV | Open-market sale | 25/02/13 | 25/02/18 | 227,500 sh | $10.43 | $2,372,825 | −58.2% |
Roivant SciencesROIV | Open-market sale10b5-1 plan | 24/09/23 | 24/09/24 | 250,000 sh | $11.89 | $2,972,500 | −54.4% |
Roivant SciencesROIV | Open-market sale | 23/09/08 | 23/09/12 | 99,350 sh | $12.18 | $1,210,083 | −33.4% |
Roivant SciencesROIV | Open-market sale | 23/09/05 | 23/09/07 | 1,724 sh | $12.00 | $20,688 | −0.9% |
ROIV | Open-market sale | 23/08/01–23/08/03 | 23/08/03 | 4,017 sh2 trades | $12.00avg. | $48,204 | −2.0% |
ROIV | Open-market sale | 23/07/14–23/07/18 | 23/07/18 | 635 sh2 trades | $12.00avg. | $7,620 | −0.8% |
Roivant SciencesROIV | Open-market sale | 23/06/09 | 23/06/13 | 43,893 sh | $9.93 | $435,857.49 | −18.1% |
ROIV | Open-market sale10b5-1 plan | 23/05/01–23/05/02 | 23/05/03 | 77,736 sh2 trades | $8.55avg. | $664,492.16 | −28.0% |
ROIV | Open-market sale10b5-1 plan | 23/04/26–23/04/28 | 23/04/28 | 230,788 sh3 trades | $8.56avg. | $1,976,057.42 | −53.6% |
